nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinacalcet—CYP1A2—Carmustine—lymphatic system cancer	0.299	0.471	CbGbCtD
Cinacalcet—CYP3A4—Cytarabine—lymphatic system cancer	0.107	0.168	CbGbCtD
Cinacalcet—CYP3A4—Teniposide—lymphatic system cancer	0.105	0.166	CbGbCtD
Cinacalcet—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0738	0.116	CbGbCtD
Cinacalcet—CYP3A4—Vincristine—lymphatic system cancer	0.0508	0.0798	CbGbCtD
Cinacalcet—Thrombosis—Mechlorethamine—lymphatic system cancer	0.013	0.0357	CcSEcCtD
Cinacalcet—Multi-organ failure—Vincristine—lymphatic system cancer	0.0112	0.0307	CcSEcCtD
Cinacalcet—Hypocalcaemia—Fludarabine—lymphatic system cancer	0.0065	0.0179	CcSEcCtD
Cinacalcet—Thrombosis—Carmustine—lymphatic system cancer	0.00538	0.0148	CcSEcCtD
Cinacalcet—Depression—Mechlorethamine—lymphatic system cancer	0.00513	0.0141	CcSEcCtD
Cinacalcet—Cardiac failure—Fludarabine—lymphatic system cancer	0.00443	0.0122	CcSEcCtD
Cinacalcet—Gastrointestinal haemorrhage—Fludarabine—lymphatic system cancer	0.00432	0.0119	CcSEcCtD
Cinacalcet—Dehydration—Fludarabine—lymphatic system cancer	0.00402	0.0111	CcSEcCtD
Cinacalcet—Hypocalcaemia—Mitoxantrone—lymphatic system cancer	0.00387	0.0106	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Fludarabine—lymphatic system cancer	0.00347	0.00955	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.0034	0.00934	CcSEcCtD
Cinacalcet—Infection—Mechlorethamine—lymphatic system cancer	0.00326	0.00896	CcSEcCtD
Cinacalcet—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00318	0.00876	CcSEcCtD
Cinacalcet—Anorexia—Mechlorethamine—lymphatic system cancer	0.00312	0.0086	CcSEcCtD
Cinacalcet—Arrhythmia—Teniposide—lymphatic system cancer	0.00304	0.00836	CcSEcCtD
Cinacalcet—Multiple fractures—Methotrexate—lymphatic system cancer	0.00304	0.00835	CcSEcCtD
Cinacalcet—Fracture—Methotrexate—lymphatic system cancer	0.00304	0.00835	CcSEcCtD
Cinacalcet—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00285	0.00784	CcSEcCtD
Cinacalcet—Gastrointestinal haemorrhage—Carmustine—lymphatic system cancer	0.00277	0.00761	CcSEcCtD
Cinacalcet—Anaemia—Teniposide—lymphatic system cancer	0.00274	0.00753	CcSEcCtD
Cinacalcet—Arrhythmia—Fludarabine—lymphatic system cancer	0.00267	0.00735	CcSEcCtD
Cinacalcet—Pain in extremity—Vincristine—lymphatic system cancer	0.00264	0.00726	CcSEcCtD
Cinacalcet—Cardiac failure—Mitoxantrone—lymphatic system cancer	0.00263	0.00725	CcSEcCtD
Cinacalcet—Malnutrition—Fludarabine—lymphatic system cancer	0.0026	0.00716	CcSEcCtD
Cinacalcet—Gastrointestinal haemorrhage—Mitoxantrone—lymphatic system cancer	0.00257	0.00707	CcSEcCtD
Cinacalcet—Hypertension—Teniposide—lymphatic system cancer	0.00256	0.00703	CcSEcCtD
Cinacalcet—Chest pain—Teniposide—lymphatic system cancer	0.00252	0.00694	CcSEcCtD
Cinacalcet—Dehydration—Vincristine—lymphatic system cancer	0.00246	0.00675	CcSEcCtD
Cinacalcet—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00242	0.00664	CcSEcCtD
Cinacalcet—Anaemia—Fludarabine—lymphatic system cancer	0.00241	0.00662	CcSEcCtD
Cinacalcet—Infection—Teniposide—lymphatic system cancer	0.0024	0.0066	CcSEcCtD
Cinacalcet—Dehydration—Mitoxantrone—lymphatic system cancer	0.00239	0.00658	CcSEcCtD
Cinacalcet—Pruritus—Mechlorethamine—lymphatic system cancer	0.00232	0.00638	CcSEcCtD
Cinacalcet—Anorexia—Teniposide—lymphatic system cancer	0.0023	0.00634	CcSEcCtD
Cinacalcet—Cough—Fludarabine—lymphatic system cancer	0.00227	0.00625	CcSEcCtD
Cinacalcet—Hypotension—Teniposide—lymphatic system cancer	0.00226	0.00621	CcSEcCtD
Cinacalcet—Convulsion—Fludarabine—lymphatic system cancer	0.00225	0.0062	CcSEcCtD
Cinacalcet—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00224	0.00617	CcSEcCtD
Cinacalcet—Myalgia—Fludarabine—lymphatic system cancer	0.00222	0.0061	CcSEcCtD
Cinacalcet—Arthralgia—Fludarabine—lymphatic system cancer	0.00222	0.0061	CcSEcCtD
Cinacalcet—Dyspnoea—Teniposide—lymphatic system cancer	0.00215	0.00593	CcSEcCtD
Cinacalcet—Depression—Carmustine—lymphatic system cancer	0.00213	0.00585	CcSEcCtD
Cinacalcet—Infection—Fludarabine—lymphatic system cancer	0.00211	0.0058	CcSEcCtD
Cinacalcet—Decreased appetite—Teniposide—lymphatic system cancer	0.0021	0.00578	CcSEcCtD
Cinacalcet—Vomiting—Mechlorethamine—lymphatic system cancer	0.00208	0.00573	CcSEcCtD
Cinacalcet—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00208	0.00573	CcSEcCtD
Cinacalcet—Rash—Mechlorethamine—lymphatic system cancer	0.00207	0.00569	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Mitoxantrone—lymphatic system cancer	0.00207	0.00568	CcSEcCtD
Cinacalcet—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00207	0.00568	CcSEcCtD
Cinacalcet—Depression—Vincristine—lymphatic system cancer	0.00203	0.00558	CcSEcCtD
Cinacalcet—Anorexia—Fludarabine—lymphatic system cancer	0.00202	0.00557	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00198	0.00544	CcSEcCtD
Cinacalcet—Bone disorder—Methotrexate—lymphatic system cancer	0.00195	0.00537	CcSEcCtD
Cinacalcet—Nausea—Mechlorethamine—lymphatic system cancer	0.00195	0.00536	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00194	0.00532	CcSEcCtD
Cinacalcet—Urticaria—Teniposide—lymphatic system cancer	0.00192	0.00528	CcSEcCtD
Cinacalcet—Abdominal pain—Teniposide—lymphatic system cancer	0.00191	0.00526	CcSEcCtD
Cinacalcet—Body temperature increased—Teniposide—lymphatic system cancer	0.00191	0.00526	CcSEcCtD
Cinacalcet—Paraesthesia—Fludarabine—lymphatic system cancer	0.00191	0.00525	CcSEcCtD
Cinacalcet—Dyspnoea—Fludarabine—lymphatic system cancer	0.00189	0.00521	CcSEcCtD
Cinacalcet—Oedema peripheral—Carmustine—lymphatic system cancer	0.00188	0.00519	CcSEcCtD
Cinacalcet—Dyspepsia—Fludarabine—lymphatic system cancer	0.00187	0.00514	CcSEcCtD
Cinacalcet—Decreased appetite—Fludarabine—lymphatic system cancer	0.00185	0.00508	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00183	0.00504	CcSEcCtD
Cinacalcet—Fatigue—Fludarabine—lymphatic system cancer	0.00183	0.00504	CcSEcCtD
Cinacalcet—Constipation—Fludarabine—lymphatic system cancer	0.00182	0.005	CcSEcCtD
Cinacalcet—Hypersensitivity—Teniposide—lymphatic system cancer	0.00178	0.0049	CcSEcCtD
Cinacalcet—Anaemia—Bleomycin—lymphatic system cancer	0.00176	0.00485	CcSEcCtD
Cinacalcet—Asthenia—Teniposide—lymphatic system cancer	0.00173	0.00477	CcSEcCtD
Cinacalcet—Pruritus—Teniposide—lymphatic system cancer	0.00171	0.0047	CcSEcCtD
Cinacalcet—Arrhythmia—Carmustine—lymphatic system cancer	0.00171	0.0047	CcSEcCtD
Cinacalcet—Body temperature increased—Fludarabine—lymphatic system cancer	0.00168	0.00462	CcSEcCtD
Cinacalcet—Malnutrition—Carmustine—lymphatic system cancer	0.00167	0.00458	CcSEcCtD
Cinacalcet—Cough—Bleomycin—lymphatic system cancer	0.00167	0.00458	CcSEcCtD
Cinacalcet—Diarrhoea—Teniposide—lymphatic system cancer	0.00165	0.00455	CcSEcCtD
Cinacalcet—Myalgia—Bleomycin—lymphatic system cancer	0.00162	0.00447	CcSEcCtD
Cinacalcet—Chest pain—Bleomycin—lymphatic system cancer	0.00162	0.00447	CcSEcCtD
Cinacalcet—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00159	0.00437	CcSEcCtD
Cinacalcet—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00156	0.0043	CcSEcCtD
Cinacalcet—Infection—Bleomycin—lymphatic system cancer	0.00155	0.00426	CcSEcCtD
Cinacalcet—Anaemia—Carmustine—lymphatic system cancer	0.00154	0.00423	CcSEcCtD
Cinacalcet—Vomiting—Teniposide—lymphatic system cancer	0.00154	0.00423	CcSEcCtD
Cinacalcet—Asthenia—Fludarabine—lymphatic system cancer	0.00152	0.00419	CcSEcCtD
Cinacalcet—Rash—Teniposide—lymphatic system cancer	0.00152	0.00419	CcSEcCtD
Cinacalcet—Dermatitis—Teniposide—lymphatic system cancer	0.00152	0.00419	CcSEcCtD
Cinacalcet—Headache—Teniposide—lymphatic system cancer	0.00151	0.00416	CcSEcCtD
Cinacalcet—Pruritus—Fludarabine—lymphatic system cancer	0.0015	0.00413	CcSEcCtD
Cinacalcet—Anorexia—Bleomycin—lymphatic system cancer	0.00148	0.00408	CcSEcCtD
Cinacalcet—Anaemia—Vincristine—lymphatic system cancer	0.00147	0.00404	CcSEcCtD
Cinacalcet—Hypotension—Bleomycin—lymphatic system cancer	0.00146	0.004	CcSEcCtD
Cinacalcet—Diarrhoea—Fludarabine—lymphatic system cancer	0.00145	0.004	CcSEcCtD
Cinacalcet—Convulsion—Carmustine—lymphatic system cancer	0.00144	0.00397	CcSEcCtD
Cinacalcet—Hypertension—Carmustine—lymphatic system cancer	0.00144	0.00396	CcSEcCtD
Cinacalcet—Nausea—Teniposide—lymphatic system cancer	0.00144	0.00395	CcSEcCtD
Cinacalcet—Anaemia—Mitoxantrone—lymphatic system cancer	0.00143	0.00394	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00142	0.0039	CcSEcCtD
Cinacalcet—Chest pain—Carmustine—lymphatic system cancer	0.00142	0.0039	CcSEcCtD
Cinacalcet—Myalgia—Carmustine—lymphatic system cancer	0.00142	0.0039	CcSEcCtD
Cinacalcet—Paraesthesia—Bleomycin—lymphatic system cancer	0.0014	0.00385	CcSEcCtD
Cinacalcet—Dyspnoea—Bleomycin—lymphatic system cancer	0.00139	0.00382	CcSEcCtD
Cinacalcet—Convulsion—Vincristine—lymphatic system cancer	0.00138	0.00379	CcSEcCtD
Cinacalcet—Hypertension—Vincristine—lymphatic system cancer	0.00137	0.00378	CcSEcCtD
Cinacalcet—Decreased appetite—Bleomycin—lymphatic system cancer	0.00135	0.00372	CcSEcCtD
Cinacalcet—Myalgia—Vincristine—lymphatic system cancer	0.00135	0.00372	CcSEcCtD
Cinacalcet—Cough—Mitoxantrone—lymphatic system cancer	0.00135	0.00372	CcSEcCtD
Cinacalcet—Infection—Carmustine—lymphatic system cancer	0.00135	0.00372	CcSEcCtD
Cinacalcet—Vomiting—Fludarabine—lymphatic system cancer	0.00135	0.00372	CcSEcCtD
Cinacalcet—Convulsion—Mitoxantrone—lymphatic system cancer	0.00134	0.00369	CcSEcCtD
Cinacalcet—Rash—Fludarabine—lymphatic system cancer	0.00134	0.00368	CcSEcCtD
Cinacalcet—Dermatitis—Fludarabine—lymphatic system cancer	0.00134	0.00368	CcSEcCtD
Cinacalcet—Hypertension—Mitoxantrone—lymphatic system cancer	0.00134	0.00368	CcSEcCtD
Cinacalcet—Headache—Fludarabine—lymphatic system cancer	0.00133	0.00366	CcSEcCtD
Cinacalcet—Chest pain—Mitoxantrone—lymphatic system cancer	0.00132	0.00363	CcSEcCtD
Cinacalcet—Myalgia—Mitoxantrone—lymphatic system cancer	0.00132	0.00363	CcSEcCtD
Cinacalcet—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00132	0.00363	CcSEcCtD
Cinacalcet—Anorexia—Carmustine—lymphatic system cancer	0.0013	0.00356	CcSEcCtD
Cinacalcet—Infection—Vincristine—lymphatic system cancer	0.00129	0.00355	CcSEcCtD
Cinacalcet—Nervous system disorder—Vincristine—lymphatic system cancer	0.00127	0.0035	CcSEcCtD
Cinacalcet—Hypotension—Carmustine—lymphatic system cancer	0.00127	0.00349	CcSEcCtD
Cinacalcet—Nausea—Fludarabine—lymphatic system cancer	0.00126	0.00347	CcSEcCtD
Cinacalcet—Infection—Mitoxantrone—lymphatic system cancer	0.00126	0.00345	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00124	0.00341	CcSEcCtD
Cinacalcet—Urticaria—Bleomycin—lymphatic system cancer	0.00124	0.0034	CcSEcCtD
Cinacalcet—Anorexia—Vincristine—lymphatic system cancer	0.00124	0.0034	CcSEcCtD
Cinacalcet—Body temperature increased—Bleomycin—lymphatic system cancer	0.00123	0.00339	CcSEcCtD
Cinacalcet—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00123	0.00338	CcSEcCtD
Cinacalcet—Paraesthesia—Carmustine—lymphatic system cancer	0.00122	0.00336	CcSEcCtD
Cinacalcet—Hypotension—Vincristine—lymphatic system cancer	0.00121	0.00334	CcSEcCtD
Cinacalcet—Dyspnoea—Carmustine—lymphatic system cancer	0.00121	0.00333	CcSEcCtD
Cinacalcet—Anorexia—Mitoxantrone—lymphatic system cancer	0.0012	0.00331	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00118	0.00325	CcSEcCtD
Cinacalcet—Decreased appetite—Carmustine—lymphatic system cancer	0.00118	0.00325	CcSEcCtD
Cinacalcet—Hypotension—Mitoxantrone—lymphatic system cancer	0.00118	0.00325	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00117	0.00323	CcSEcCtD
Cinacalcet—Paraesthesia—Vincristine—lymphatic system cancer	0.00117	0.00321	CcSEcCtD
Cinacalcet—Constipation—Carmustine—lymphatic system cancer	0.00116	0.0032	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00115	0.00317	CcSEcCtD
Cinacalcet—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00115	0.00316	CcSEcCtD
Cinacalcet—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00113	0.00312	CcSEcCtD
Cinacalcet—Decreased appetite—Vincristine—lymphatic system cancer	0.00113	0.0031	CcSEcCtD
Cinacalcet—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00113	0.0031	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00112	0.00308	CcSEcCtD
Cinacalcet—Fatigue—Vincristine—lymphatic system cancer	0.00112	0.00308	CcSEcCtD
Cinacalcet—Asthenia—Bleomycin—lymphatic system cancer	0.00112	0.00307	CcSEcCtD
Cinacalcet—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00111	0.00306	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00111	0.00306	CcSEcCtD
Cinacalcet—Constipation—Vincristine—lymphatic system cancer	0.00111	0.00305	CcSEcCtD
Cinacalcet—Pruritus—Bleomycin—lymphatic system cancer	0.0011	0.00303	CcSEcCtD
Cinacalcet—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.0011	0.00302	CcSEcCtD
Cinacalcet—Fatigue—Mitoxantrone—lymphatic system cancer	0.00109	0.003	CcSEcCtD
Cinacalcet—Constipation—Mitoxantrone—lymphatic system cancer	0.00108	0.00297	CcSEcCtD
Cinacalcet—Body temperature increased—Carmustine—lymphatic system cancer	0.00107	0.00296	CcSEcCtD
Cinacalcet—Abdominal pain—Carmustine—lymphatic system cancer	0.00107	0.00296	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00106	0.00292	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00103	0.00284	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00103	0.00283	CcSEcCtD
Cinacalcet—Abdominal pain—Vincristine—lymphatic system cancer	0.00103	0.00282	CcSEcCtD
Cinacalcet—Body temperature increased—Vincristine—lymphatic system cancer	0.00103	0.00282	CcSEcCtD
Cinacalcet—Urticaria—Mitoxantrone—lymphatic system cancer	0.001	0.00276	CcSEcCtD
Cinacalcet—Hypersensitivity—Carmustine—lymphatic system cancer	0.001	0.00276	CcSEcCtD
Cinacalcet—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000999	0.00275	CcSEcCtD
Cinacalcet—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000999	0.00275	CcSEcCtD
Cinacalcet—Vomiting—Bleomycin—lymphatic system cancer	0.00099	0.00272	CcSEcCtD
Cinacalcet—Depression—Methotrexate—lymphatic system cancer	0.000984	0.00271	CcSEcCtD
Cinacalcet—Rash—Bleomycin—lymphatic system cancer	0.000982	0.0027	CcSEcCtD
Cinacalcet—Dermatitis—Bleomycin—lymphatic system cancer	0.000981	0.0027	CcSEcCtD
Cinacalcet—Asthenia—Carmustine—lymphatic system cancer	0.000975	0.00268	CcSEcCtD
Cinacalcet—Hypersensitivity—Vincristine—lymphatic system cancer	0.000956	0.00263	CcSEcCtD
Cinacalcet—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000931	0.00256	CcSEcCtD
Cinacalcet—Asthenia—Vincristine—lymphatic system cancer	0.000931	0.00256	CcSEcCtD
Cinacalcet—Diarrhoea—Carmustine—lymphatic system cancer	0.00093	0.00256	CcSEcCtD
Cinacalcet—Nausea—Bleomycin—lymphatic system cancer	0.000925	0.00254	CcSEcCtD
Cinacalcet—Asthenia—Mitoxantrone—lymphatic system cancer	0.000907	0.00249	CcSEcCtD
Cinacalcet—Dizziness—Carmustine—lymphatic system cancer	0.000899	0.00247	CcSEcCtD
Cinacalcet—Diarrhoea—Vincristine—lymphatic system cancer	0.000888	0.00244	CcSEcCtD
Cinacalcet—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000865	0.00238	CcSEcCtD
Cinacalcet—Vomiting—Carmustine—lymphatic system cancer	0.000864	0.00238	CcSEcCtD
Cinacalcet—Dizziness—Vincristine—lymphatic system cancer	0.000858	0.00236	CcSEcCtD
Cinacalcet—Rash—Carmustine—lymphatic system cancer	0.000857	0.00236	CcSEcCtD
Cinacalcet—Dermatitis—Carmustine—lymphatic system cancer	0.000856	0.00236	CcSEcCtD
Cinacalcet—Headache—Carmustine—lymphatic system cancer	0.000852	0.00234	CcSEcCtD
Cinacalcet—Vomiting—Vincristine—lymphatic system cancer	0.000825	0.00227	CcSEcCtD
Cinacalcet—Rash—Vincristine—lymphatic system cancer	0.000818	0.00225	CcSEcCtD
Cinacalcet—Dermatitis—Vincristine—lymphatic system cancer	0.000817	0.00225	CcSEcCtD
Cinacalcet—Headache—Vincristine—lymphatic system cancer	0.000813	0.00224	CcSEcCtD
Cinacalcet—Nausea—Carmustine—lymphatic system cancer	0.000807	0.00222	CcSEcCtD
Cinacalcet—Vomiting—Mitoxantrone—lymphatic system cancer	0.000804	0.00221	CcSEcCtD
Cinacalcet—Immune system disorder—Methotrexate—lymphatic system cancer	0.000801	0.0022	CcSEcCtD
Cinacalcet—Rash—Mitoxantrone—lymphatic system cancer	0.000797	0.00219	CcSEcCtD
Cinacalcet—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000796	0.00219	CcSEcCtD
Cinacalcet—Headache—Mitoxantrone—lymphatic system cancer	0.000792	0.00218	CcSEcCtD
Cinacalcet—Malnutrition—Methotrexate—lymphatic system cancer	0.000772	0.00212	CcSEcCtD
Cinacalcet—Nausea—Vincristine—lymphatic system cancer	0.000771	0.00212	CcSEcCtD
Cinacalcet—Nausea—Mitoxantrone—lymphatic system cancer	0.000751	0.00206	CcSEcCtD
Cinacalcet—Anaemia—Methotrexate—lymphatic system cancer	0.000713	0.00196	CcSEcCtD
Cinacalcet—Cough—Methotrexate—lymphatic system cancer	0.000673	0.00185	CcSEcCtD
Cinacalcet—Convulsion—Methotrexate—lymphatic system cancer	0.000668	0.00184	CcSEcCtD
Cinacalcet—Myalgia—Methotrexate—lymphatic system cancer	0.000657	0.00181	CcSEcCtD
Cinacalcet—Arthralgia—Methotrexate—lymphatic system cancer	0.000657	0.00181	CcSEcCtD
Cinacalcet—Chest pain—Methotrexate—lymphatic system cancer	0.000657	0.00181	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000652	0.00179	CcSEcCtD
Cinacalcet—Infection—Methotrexate—lymphatic system cancer	0.000626	0.00172	CcSEcCtD
Cinacalcet—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000618	0.0017	CcSEcCtD
Cinacalcet—Skin disorder—Methotrexate—lymphatic system cancer	0.000612	0.00168	CcSEcCtD
Cinacalcet—Anorexia—Methotrexate—lymphatic system cancer	0.0006	0.00165	CcSEcCtD
Cinacalcet—Hypotension—Methotrexate—lymphatic system cancer	0.000588	0.00162	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000574	0.00158	CcSEcCtD
Cinacalcet—Paraesthesia—Methotrexate—lymphatic system cancer	0.000565	0.00156	CcSEcCtD
Cinacalcet—Dyspnoea—Methotrexate—lymphatic system cancer	0.000561	0.00154	CcSEcCtD
Cinacalcet—Dyspepsia—Methotrexate—lymphatic system cancer	0.000554	0.00152	CcSEcCtD
Cinacalcet—Decreased appetite—Methotrexate—lymphatic system cancer	0.000547	0.00151	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000544	0.0015	CcSEcCtD
Cinacalcet—Fatigue—Methotrexate—lymphatic system cancer	0.000543	0.00149	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000515	0.00142	CcSEcCtD
Cinacalcet—Urticaria—Methotrexate—lymphatic system cancer	0.0005	0.00138	CcSEcCtD
Cinacalcet—Abdominal pain—Methotrexate—lymphatic system cancer	0.000498	0.00137	CcSEcCtD
Cinacalcet—Body temperature increased—Methotrexate—lymphatic system cancer	0.000498	0.00137	CcSEcCtD
Cinacalcet—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000464	0.00128	CcSEcCtD
Cinacalcet—Asthenia—Methotrexate—lymphatic system cancer	0.000452	0.00124	CcSEcCtD
Cinacalcet—Pruritus—Methotrexate—lymphatic system cancer	0.000445	0.00123	CcSEcCtD
Cinacalcet—Diarrhoea—Methotrexate—lymphatic system cancer	0.000431	0.00119	CcSEcCtD
Cinacalcet—Dizziness—Methotrexate—lymphatic system cancer	0.000416	0.00115	CcSEcCtD
Cinacalcet—Vomiting—Methotrexate—lymphatic system cancer	0.0004	0.0011	CcSEcCtD
Cinacalcet—Rash—Methotrexate—lymphatic system cancer	0.000397	0.00109	CcSEcCtD
Cinacalcet—Dermatitis—Methotrexate—lymphatic system cancer	0.000397	0.00109	CcSEcCtD
Cinacalcet—Headache—Methotrexate—lymphatic system cancer	0.000394	0.00109	CcSEcCtD
Cinacalcet—Nausea—Methotrexate—lymphatic system cancer	0.000374	0.00103	CcSEcCtD
